These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22157039)

  • 1. F-18 FDG uptake in hemorrhoids in a patient with diffuse large B-cell lymphoma.
    Thientunyakit T; Lee ST; Berlangieri S
    Clin Nucl Med; 2012 Jan; 37(1):91-2. PubMed ID: 22157039
    [No Abstract]   [Full Text] [Related]  

  • 2. Intense focal pituitary FDG uptake due to intravascular large B-cell lymphoma in pyrexia of unknown origin.
    Pattison DA; Hofman MS; Bazargan A; Colman P; Hicks RJ
    Am J Hematol; 2016 Nov; 91(11):1167-1168. PubMed ID: 27387341
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma.
    Koga H; Matsuo Y; Sasaki M; Nakagawa M; Kaneko K; Hayashi K; Kuwabara Y; Honda H
    Ann Nucl Med; 2003 Jun; 17(4):327-31. PubMed ID: 12932118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse F-18 FDG uptake in skeletal muscles secondary to chills resulting from sepsis: a cause for underestimation of viable tumor.
    Ojha B; Muthukrishnan A; Raman AK; Satya R; Mahone T; Forero-Torres A
    Clin Nucl Med; 2004 Sep; 29(9):600-1. PubMed ID: 15311141
    [No Abstract]   [Full Text] [Related]  

  • 5. [18F-FDG uptake of lymphoma lesions of various histological subtypes].
    Ma LF; Fan W
    Ai Zheng; 2009 Apr; 28(4):425-30. PubMed ID: 19622306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-18 FDG uptake due to acinetobacter infection causing misinterpretation of treatment response in a lymphoma patient.
    Yildiz R; Coskun U; Kapucu O; Kaya AO; Akdemir UO; Benekli M; Buyukberber S
    Clin Nucl Med; 2007 Jun; 32(6):471-3. PubMed ID: 17515759
    [No Abstract]   [Full Text] [Related]  

  • 7. Findings of 2-fluoro-2-deoxy-d-glucose positron emission tomography in hemorrhoids.
    Tsai SC; Jeng LB; Yeh JJ; Lin CC; Chen JH; Lin WY; Kao CH
    Abdom Imaging; 2011 Oct; 36(5):548-51. PubMed ID: 21153025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 18F-FDG-positive, 67Ga-negative, and transferrin receptor expression-negative patient with diffuse large B-cell lymphoma.
    Tsujikawa T; Okazawa H; Tsuchida T; Demura Y; Imamura Y; Fujibayashi Y
    Ann Nucl Med; 2007 Aug; 21(6):375-8. PubMed ID: 17705020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized uptake value for (18)F-fluorodeoxyglucose is correlated with a high International Prognostic Index and the presence of extranodal involvement in patients with diffuse large B-cell lymphoma.
    Akkas BE; Vural GU
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):148-52. PubMed ID: 24094371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body muscle gallium uptake in a large B-cell non-Hodgkin lymphoma.
    Lorenzo-Bosquet C; Navarrete M; Rubió A; López A; Castell-Conesa J
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1452. PubMed ID: 15221287
    [No Abstract]   [Full Text] [Related]  

  • 11. [F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model.
    Chaise C; Itti E; Petegnief Y; Wirquin E; Copie-Bergman C; Farcet JP; Delfau-Larue MH; Meignan M; Talbot JN; Molinier-Frenkel V
    Cancer Immunol Immunother; 2007 Aug; 56(8):1163-71. PubMed ID: 17171356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
    Kumar R; Xiu Y; Zhuang HM; Alavi A
    Br J Dermatol; 2006 Aug; 155(2):357-63. PubMed ID: 16882175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.
    Weiler-Sagie M; Bushelev O; Epelbaum R; Dann EJ; Haim N; Avivi I; Ben-Barak A; Ben-Arie Y; Bar-Shalom R; Israel O
    J Nucl Med; 2010 Jan; 51(1):25-30. PubMed ID: 20009002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythema nodosum associated with diffuse, large B-cell non-Hodgkin lymphoma detected by FDG PET.
    Cheong KA; Rodgers NG; Kirkwood ID
    Clin Nucl Med; 2003 Aug; 28(8):652-4. PubMed ID: 12897650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
    Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B- and T-cell lymphomas.
    Chan WK; Au WY; Wong CY; Liang R; Leung AY; Kwong YL; Khong PL
    Clin Nucl Med; 2010 Aug; 35(8):571-5. PubMed ID: 20631501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell lymphoma: a case with localized involvement of the prostate on F-18-FDG examination.
    Solis V; Rosenberg RJ; Spencer RP
    Clin Nucl Med; 2005 Apr; 30(4):236-7. PubMed ID: 15764877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alteration of 18F-FDG uptake in bone marrow after treatment with interleukin 11.
    Yi C; Shi X; Wang X; Chen Z; Zhang B; Zhang X
    Clin Nucl Med; 2014 Oct; 39(10):934-5. PubMed ID: 25036016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intense F-18 FDG uptake in the stomach wall in follicular gastritis in Zollinger-Ellison syndrome.
    Basu S; Nair N
    Clin Nucl Med; 2007 Feb; 32(2):150-1. PubMed ID: 17242575
    [No Abstract]   [Full Text] [Related]  

  • 20. (18)F-FDG and (18)F-FLT uptake early after cyclophosphamide and mTOR inhibition in an experimental lymphoma model.
    Brepoels L; Stroobants S; Verhoef G; De Groot T; Mortelmans L; De Wolf-Peeters C
    J Nucl Med; 2009 Jul; 50(7):1102-9. PubMed ID: 19525456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.